Gene: OGA
Official Full Name: O-GlcNAcaseprovided by HGNC
Gene Summary: The dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (MIM 300255), which adds O-GlcNAc, and MGEA5, a glycosidase that removes O-GlcNAc modifications (Gao et al., 2001 [PubMed 11148210]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06974 | OGA Knockout cell line (HeLa) | Human | OGA | 1:3~1:6 | Negative | Online Inquiry |
KO06975 | OGA Knockout cell line (HCT 116) | Human | OGA | 1:2~1:4 | Negative | Online Inquiry |
KO06976 | OGA Knockout cell line (HEK293) | Human | OGA | 1:3~1:6 | Negative | Online Inquiry |
KO06977 | OGA Knockout cell line (A549) | Human | OGA | 1:3~1:4 | Negative | Online Inquiry |
OGA Gene Knockout Cell Lines are genetically engineered cell models that have been methodically designed to lack functional O-GlcNAcase (OGA) expression, an enzyme critical for modulating protein glycosylation through the removal of O-linked N-acetylglucosamine (O-GlcNAc) residues. By enabling the study of OGA's role within cellular processes, these knockout cell lines serve as invaluable tools for elucidating the intricate mechanisms of glycosylation that influence various physiological and pathological conditions, such as cancer, diabetes, and neurodegenerative diseases.
The key functions of OGA are centered on its involvement in the dynamic regulation of the O-GlcNAc modification cycle, where it counterbalances O-GlcNAc transferase (OGT) activity. The absence of OGA in these knockout cell lines leads to elevated levels of O-GlcNAc-modified proteins, establishing a unique cellular environment conducive to investigating downstream effects on signaling pathways, transcriptional regulation, and metabolic alterations. This provides researchers with a versatile platform for assessing the biochemical ramifications of altered glycosylation.
The scientific importance of OGA Gene Knockout Cell Lines extends to their myriad applications in both research and clinical settings. They are pivotal in drug discovery processes, particularly in identifying potential OGA inhibitors that could serve as therapeutic agents in the treatment of diseases linked to aberrant glycosylation patterns. Additionally, these cell lines offer a robust system for pharmacological testing, helping to validate targets and optimize lead compounds aimed at modulating O-GlcNAc signaling pathways.
Compared to alternative models, OGA Gene Knockout Cell Lines stand out due to their precise genetic alterations, which eliminate confounding variables associated with off-target effects often observed in non-specific knockdowns. Furthermore, the continued metabolic stability of these cells enhances their usability across a range of experimentation methods.
For researchers and clinicians dedicated to uncovering the complexities of glycosylation, OGA Gene Knockout Cell Lines are indispensable tools that facilitate groundbreaking discovery and innovation. Our company specializes in the development of high-quality genetic models backed by rigorous scientific validation, ensuring that researchers receive products that meet their experimental needs and drive significant advancements in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.